ZBH — Zimmer Biomet Holdings Income Statement
0.000.00%
Last trade - 00:00
- $24.54bn
- $29.90bn
- $7.39bn
- 95
- 36
- 77
- 79
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,982 | 6,128 | 6,827 | 6,940 | 7,394 |
Cost of Revenue | |||||
Gross Profit | 5,730 | 4,303 | 4,867 | 4,920 | 5,310 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,845 | 6,044 | 6,132 | 6,244 | 6,117 |
Operating Profit | 1,138 | 83.1 | 695 | 696 | 1,278 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 906 | -105 | 499 | 404 | 1,067 |
Provision for Income Taxes | |||||
Net Income After Taxes | 817 | -9.2 | 446 | 291 | 1,025 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,132 | -139 | 402 | 231 | 1,024 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,132 | -139 | 402 | 231 | 1,024 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.72 | 2.06 | 3.66 | 3.2 | 5.78 |
Dividends per Share |